Table 4.
Number of clones for specimens from patient A (GT-1a infected), treated QD with 1 mg of DCV
Mutation(s) | No. of clones at the indicated time point |
||||
---|---|---|---|---|---|
T0 | T12 | D14-1a | D14-2a | D42 | |
None (WT) | 93 | 87 | 3 | ||
M28T | 1 | 49 | 49 | 27 | |
Q30H | 24 | 5 | 14 | ||
Q30K | 2 | ||||
Q30R | 2 | 31 | 15 | 33 | |
L31M | 12 | 9 | |||
H58D | 4 | ||||
Y93C | 13 | 2 | |||
Y93N | 1 | ||||
M28T-Y93C | 2 | ||||
Q30R-L31P | 1 | ||||
L31M-Y93C | 1 | ||||
Total | 96 | 88 | 104 | 100 | 92 |
Two different primer sets (-1 and -2) were used for the same specimen derived from day 14.